Abstract:Objective To establish and improve the acute hepatic failure model in pigs induced with D-galactosamine (D-gal),and explore the feasibility of evaluating preclinical artificial liver devices.Methods Nineteen Duroc breeding pigs were divided into 4 groups.Fifteen unanesthetic Duroc breeding pigs out of 19 (5 of each group) received intravenously administration of D-gal at a dose of 1.0,1.25 and 1.5 g/kg body weight,respectively.The remaining 4 pigs which received the same volume of 5% dextrose in water served as controls. Clinical data and survival time of pigs were recorded.Blood samples were collected for dynamic testing of plasma ammonia,prothrombin time,liver and renal functions,blood glucose and L-lactate;liver tissues were sampled for pathological examination.The differences between groups were compared using t test and F test.The survival time of pigs was compared by Kaplan-Meier survival analysis and Log Rank test.Results Twelve hours after administration of D-gal,all pigs presented as acute hepatic failure characterized by progressive increases of levels of plasma ammonia,aspartate aminotransferase (AST),total bilirubin (TBil) and L-lactate,the level of blood glucose marked decreased and prothrombin time prolonged (F= 32.33,F=27.817,F=50.097,F=88.382,F=8.211,F=21.227;all P＜0.01);especially in the pigs which received D-gal at a dose of 1.5 g/kg.Except 2 pigs survived for 168 h,the other 3 pigs which received D-gal at a dose of 1.0 g/kg died within 68-84 h,while all pigs which received D-gal at a dose of 1.25 and 1.5 g/kg died within 33-89 h and 23-47 h,respectively.All pigs presented coma before death and liver histopathological examination indicated massive hepatic necrosis with severe hemorrhage.Conclusions D-gal induced acute hepatic failure model in unanesthetic Duroc breeding pig appears potential reversibility and high reproducibility,which has proper therapeutic window.Thus,this model could be applied to evaluate the therapeutic effects and safety of artificial liver devices.

Experimental 3-nitro-4-hydroxyphenylarsonic acid toxicosis in pigs

Neuropathology of experimental 3-nitro-4-hydroxyphenylarsonic acid toxicosis in pigs

Roxarsone (3-nitro-4-hydroxyphenylarsonic acid) poisoning in pigs

Kinetics of aristolochic acid I after oral administration of Radix Aristolochiae or Guanxinsuhe preparation in canines.

Distribution And Speciation Of Arsenic After Intravenous Administration Of Monomethylmonothioarsonic Acid In Rats

PSIII-29 Feeding arsenic-containing rice bran to growing pigs: arsenic distribution in major tissues

Effects of Arsenic (As-Iii) on Lipid Peroxidation, Glutathione Content and Antioxidant Enzymes in Growing Pigs

Pathologic features of adriamycin toxicosis in young pigs: nonskeletal lesions

Feeding Arsenic-Containing Rice Bran to Growing Pigs: Growth Performance, Arsenic Tissue Distribution, and Arsenic Excretion

Hepatic histopathological changes and dysfunction in primates following exposure to organic arsenic diphenylarsinic acid

Arsenic poisoning in livestock

Atypical porcine enterovirus encephalomyelitis: possible interraction between enteroviruses and arsenicals

Systemic Distribution and Speciation of Diphenylarsinic Acid Fed to Rats

Bovine arsenic toxicosis from ingestion of ashed copper-chrome-arsenate treated timber

Metabolism and Effects on Endogenous Metabolism of Paracetamol (Acetaminophen) in a Porcine Model of Liver Failure

Hepatic Premalignant Alterations Triggered by Human Nephrotoxin Aristolochic Acid I in Canines

Establishment and further improvement of D-galactosamine induced acute hepatic failure in Duroc breeding pigs

Arsanilic acid-induced blindness in swine: electroretinographic and visually evoked responses

Effects of dietary arsenic levels on serum parameters and trace mineral retentions in growing and finishing pigs

Experimental mycotoxic nephropathy in pigs provoked by a diet containing ochratoxin A and penicillic acid

Arsenic-sulfur amino acid interactions in the chick